BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37108649)

  • 1. VCAN Hypomethylation and Expression as Predictive Biomarkers of Drug Sensitivity in Upper Urinary Tract Urothelial Carcinoma.
    Luo HL; Chang YL; Liu HY; Wu YT; Sung MT; Su YL; Huang CC; Wang PC; Peng JM
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion.
    Godfrey MS; Badalato GM; Hruby GW; Razmjoo M; McKiernan JM
    BJU Int; 2012 Sep; 110(6):798-803. PubMed ID: 22313599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility and concordance of upper urinary tract cytology and biopsy in predicting clinicopathological features of upper urinary tract urothelial carcinoma.
    Simon CT; Skala SL; Weizer AZ; Ambani SN; Chinnaiyan AM; Palapattu G; Hafez K; Magers MJ; Kaffenberger SD; Spratt DE; Montgomery JS; Morgan TM; Udager AM; Lew M; Mehra R
    Hum Pathol; 2019 Apr; 86():76-84. PubMed ID: 30537495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of Versican Associated with Tumor Progression, Metastasis, and Poor Prognosis in Bladder Carcinoma.
    Zhang Q; Wu J; Chen X; Zhao M; Zhang D; Gao F
    Biomed Res Int; 2021; 2021():6949864. PubMed ID: 33604385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA Hypomethylation Is Associated with the Overexpression of INHBA in Upper Tract Urothelial Carcinoma.
    Kao CC; Chang YL; Liu HY; Wu ST; Meng E; Cha TL; Sun GH; Yu DS; Luo HL
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Versican Promotes Tumor Progression, Metastasis and Predicts Poor Prognosis in Renal Carcinoma.
    Mitsui Y; Shiina H; Kato T; Maekawa S; Hashimoto Y; Shiina M; Imai-Sumida M; Kulkarni P; Dasgupta P; Wong RK; Hiraki M; Arichi N; Fukuhara S; Yamamura S; Majid S; Saini S; Deng G; Dahiya R; Nakajima K; Tanaka Y
    Mol Cancer Res; 2017 Jul; 15(7):884-895. PubMed ID: 28242813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypomethylated RRBP1 Potentiates Tumor Malignancy and Chemoresistance in Upper Tract Urothelial Carcinoma.
    Luo HL; Liu HY; Chang YL; Sung MT; Chen PY; Su YL; Huang CC; Peng JM
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder.
    van Doeveren T; Nakauma-Gonzalez JA; Mason AS; van Leenders GJLH; Zuiverloon TCM; Zwarthoff EC; Meijssen IC; van der Made AC; van der Heijden AG; Hendricksen K; van Rhijn BWG; Voskuilen CS; van Riet J; Dinjens WNM; Dubbink HJ; van de Werken HJG; Boormans JL
    Int J Cancer; 2021 Feb; 148(4):981-987. PubMed ID: 33006377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of stromal periostin expression in upper urinary tract urothelial carcinoma.
    Miyai K; Kawamura K; Ito K; Matsukuma S; Tsuda H
    BMC Cancer; 2022 Jul; 22(1):787. PubMed ID: 35850759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression Analysis of Same-Patient Metachronous and Synchronous Upper Tract and Bladder Urothelial Carcinoma.
    Petros FG; Choi W; Qi Y; Moss T; Li R; Su X; Guo CC; Czerniak B; Dinney C; McConkey DJ; Matin SF
    J Urol; 2021 Sep; 206(3):548-557. PubMed ID: 33881933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between lymphovascular invasion and oncological outcome in node-negative upper tract urothelial carcinoma with different stage.
    Chen CS; Lin CY; Wang CL; Wang SS; Li JR; Yang CK; Cheng CL; Chiu KY; Yang SF
    Urol Oncol; 2021 Feb; 39(2):132.e13-132.e26. PubMed ID: 32900630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synchronous and metachronous urothelial carcinoma of the upper urinary tract and the bladder: Are they clonally related? A systematic review.
    van Doeveren T; van de Werken HJG; van Riet J; Aben KKH; van Leeuwen PJ; Zwarthoff EC; Boormans JL
    Urol Oncol; 2020 Jun; 38(6):590-598. PubMed ID: 32057596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of Chitinase 3-like-1 is an unfavorable prognostic factor in urothelial carcinoma of upper urinary tract and urinary bladder.
    Lee YE; Chan TC; Tian YF; Liang PI; Shiue YL; Chen YS; He HL
    Urol Oncol; 2019 May; 37(5):299.e7-299.e18. PubMed ID: 30660494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma.
    D'Andrea D; Matin S; Black PC; Petros FG; Zargar H; Dinney CP; Cookson MS; Kassouf W; Dall'Era MA; McGrath JS; Wright JL; Thorpe AC; Morgan TM; Holzbeierlein JM; Bivalacqua TJ; Sridhar SS; North S; Barocas DA; Lotan Y; Stephenson AJ; van Rhijn BW; Spiess PE; Daneshmand S; Shariat SF
    BJU Int; 2021 May; 127(5):528-537. PubMed ID: 32981193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic Characterization of Upper Tract Urothelial Carcinoma.
    Sfakianos JP; Cha EK; Iyer G; Scott SN; Zabor EC; Shah RH; Ren Q; Bagrodia A; Kim PH; Hakimi AA; Ostrovnaya I; Ramirez R; Hanrahan AJ; Desai NB; Sun A; Pinciroli P; Rosenberg JE; Dalbagni G; Schultz N; Bajorin DF; Reuter VE; Berger MF; Bochner BH; Al-Ahmadie HA; Solit DB; Coleman JA
    Eur Urol; 2015 Dec; 68(6):970-7. PubMed ID: 26278805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of diagnostic criteria for upper urinary tract urothelial carcinoma based on genome-wide DNA methylation analysis.
    Fujimoto M; Arai E; Tsumura K; Yotani T; Yamada Y; Takahashi Y; Maeshima AM; Fujimoto H; Yoshida T; Kanai Y
    Epigenetics; 2020 Dec; 15(12):1289-1301. PubMed ID: 32498593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct patterns and behaviour of urothelial carcinoma with respect to anatomical location: how molecular biomarkers can augment clinico-pathological predictors in upper urinary tract tumours.
    Yates DR; Catto JW
    World J Urol; 2013 Feb; 31(1):21-9. PubMed ID: 22986906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpressed versican promoted cell multiplication, migration and invasion in gastric cancer.
    Zhai L; Chen W; Cui B; Yu B; Wang Y; Liu H
    Tissue Cell; 2021 Dec; 73():101611. PubMed ID: 34358918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histological variants and lymphovascular invasion in upper tract urothelial carcinoma can stratify prognosis after radical nephroureterectomy.
    Takemoto K; Hayashi T; Hsi RS; Kobatake K; Sekino Y; Kitano H; Ikeda K; Goto K; Hieda K; Sentani K; Kajiwara M; Nishizaka T; Teishima J; Oue N; Hinata N
    Urol Oncol; 2022 Dec; 40(12):539.e9-539.e16. PubMed ID: 36244916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.